Lepromatous Leprosy: A Case Report

Authors

Humaira Shamim Allama Iqbal Medical College
Wasfa Hayat Allama Iqbal Medical College, Lahore Lahore Pakistan
Mehwish Jahangir Allama Iqbal Medical College, Lahore Lahore Pakistan
Hira Fatiam Allama Iqbal Medical College, Lahore Lahore Pakistan
Salma Naeem Allama Iqbal Medical College, Lahore Lahore Pakistan
Nadia Ali Azfar Allama Iqbal Medical College, Lahore Lahore Pakistan

DOI:

https://doi.org/10.51273/esc25.251321135

Keywords:

Lepromatous leprosy, mycobacterium leprae, multibacillary

Abstract

Abstract
Background: Leprosy is a chronic infection with an incubation period of 2 to 6 years. It is a contagious
infection caused by mycobacterium leprae. It is present in multibacillary (lepromatous) and paucibacillary
(tuberculoid) forms affecting the skin and mucosa. The cutaneous findings range from hypopigmented to
hyperpigmented patches, plaques, and ulcerative lesions. Mucosal involvement can damage the palate,
tongue, nose, lips, and gum. Leprosy is usually diagnosed by clinical evaluation and is confirmed by
laboratory analysis. Treatment includes drug therapy such as Dapsone, Rifampicin, and Clofazimine. If left
untreated, it can cause permanent physical deformities and social stigma. Despite being curable, leprosy
remains prevalent in underdeveloped areas of the world, such as South Asian countries and Brazil.
Prophylaxis and control depend on early diagnosis and the active search of contacts at risk of acquiring the
disease. Herein, we report a case of presenting with ulcerations and debilitating deformities and diagnosed as
lepromatous leprosy.
Keywords: lepromatous leprosy, mycobacterium leprae, multibacillary
How to cite: Shamim H, Hayat W, Jahangir M, Fatiam H, Naeem S, Azfar NA. Lepromatous Leprosy: A Case Report.
Esculapio - JSIMS 2025;21(01): 195-198
DOI: https://doi.org/10.51273/esc25.251321134

References

Gómez-Cerquera JM, Herrera-Darias S, Domingo-

Amela A, Graells-Estrada J. Lepromatous leprosy.

Med Clin (Barc). 2022 Dec 9;159(11):556. English,

Spanish. doi: 10.1016/j.medcli.2022.07.015.

Neema S, Battula S. Lepromatous Leprosy. N Engl J

Med. 2022 Sep 29;387(13):1217. doi: 10.1056/-

NEJMicm2202533.

Goel S, Gogia K, Singla R, Gupta S, Patel K, Verma

S. Lepromatous leprosy with central serous

chorioretinopathy. Indian J Dermatol Venereol

Leprol. 2022 Nov-Dec;88(6):807-811. doi:

25259/IJDVL_1100_20.

Poondru S, Shi V, Rajpara A. Leonine Facies of

Lepromatous Leprosy. JAMA Dermatol. 2023 Dec

; 1 5 9 ( 1 2 ) : 1 3 8 5 - 1 3 8 6 . d o i : 1 0 . 1 0 0 1 / -

jamadermatol.2023.3062.

Dong G, Jia Y. Facies Leonine in Lepromatous

Leprosy. J Cutan Med Surg. 2022 Jul-Aug;26(4):439.

doi: 10.1177/12034754211064310.

Quintarelli L, Magnaterra E, Maglie R, Corrà A,

Ruffo di Calabria V, Aimo C, Mariotti EB, Verdelli A,

Maio V, Antiga E, Caproni M. Lepromatous leprosy

presenting with erythema nodosum leprosum

mimicking Bechet's disease. Travel Med Infect Dis.

Mar-Apr;52:102521. doi: 10.1016/-

j.tmaid.2022.102521.

Palaniappan V, Karthikeyan K. Leonine facies and

madarosis in lepromatous leprosy. Postgrad Med J.

Dec;98(1166):e36. doi: 10.1136/postgradmedj-

-141061.

Domozych R, Kim E, Hart S, Greenwald J.

Increasing incidence of leprosy and transmission

from armadillos in Central Florida: A case series.

JAAD Case Rep. 2016 May 12;2(3):189-92. doi:

1016/j.jdcr.2016.03.004.

Alfaragi M, Ahmed F, Osman W, Mustafa I,

Almustafi I, Dawoud R, Alrashdi F. Challenges

related to the cases of lepromatous leprosy: a report of

two cases. Pan Afr Med J. 2022 Jan 13;41:35. doi:

11604/pamj.2022.41.35.32318.

Degechisa ST, Dabi YT. Leptin Deficiency May

Influence the Divergence of Cell-Mediated

Immunity Between Lepromatous and Tuberculoid

Leprosy Patients. J Inflamm Res. 2022 Dec

;15:6719-6728. doi: 10.2147/JIR.S389845.

Kimta N, Majdalawieh AF, Nasrallah GK, Puri S,

Nepovimova E, Jomova K, Kuča K. Leprosy:

Comprehensive insights into pathology,

immunology, and cutting-edge treatment strategies,

integrating nanoparticles and ethnomedicinal plants.

Front Pharmacol. 2024 May 16;15:1361641. doi:

3389/fphar.2024.1361641.

Beauvillain Q, Lok C, Joachim C, Hamdad F,

Lafabregue E, Attencourt C, Sevestre H, Chaby G.

Autochthonous leprosy in Europe: a case report and

literature review. Int J Infect Dis. 2021 Sep;110:111-

doi: 10.1016/j.ijid.2021.07.023.

Bhat RM, Vaidya TP. What is New in the

Pathogenesis and Management of Erythema

Nodosum Leprosum. Indian Dermatol Online J. 2020

J u l 1 3 ; 11 ( 4 ) : 4 8 2 - 4 9 2 . d o i : 1 0 . 4 1 0 3 / -

idoj.IDOJ_561_19.

de Macedo CS, Lara FA, Pinheiro RO, Schmitz V, de

Berrêdo-Pinho M, Pereira GM, Pessolani MCV. New

insights into the pathogenesis of leprosy:

contribution of subversion of host cell metabolism to

bacterial persistence, disease progression, and

transmission. F1000Res. 2020 Jan 31;9:F1000

F a c u l t y R e v - 7 0 . d o i : 1 0 . 1 2 6 8 8 / -

f1000research.21383.1.

Sahu S, Sharma K, Sharma M, Narang T, Dogra S,

Minz RW, Chhabra S. Neutrophil NETworking in

ENL: Potential as a Putative Biomarker: Future

Insights. Front Med (Lausanne). 2021 Jul

;8:697804. doi: 10.3389/fmed.2021.697804.

Deps P, Collin SM. Mycobacterium lepromatosis as a

Second Agent of Hansen's Disease. Front Microbiol.

Sep 10;12:698588. doi: 10.3389/-

fmicb.2021.698588.

Downloads

Published

2025-03-31

How to Cite

Humaira Shamim, Wasfa Hayat, Mehwish Jahangir, Hira Fatiam, Salma Naeem, Nadia Ali Azfar. Lepromatous Leprosy: A Case Report. Esculapio - JSIMS [Internet]. 2025 Mar. 31 [cited 2025 May 13];21(1):199-202. Available from: https://esculapio.pk/journal/index.php/journal-files/article/view/1371